After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health

Quick Summary:

The DNA-testing firm said in a Tuesday SEC filing, "there is substantial doubt about the company’s ability to continue.

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Sasha Rogelberg

Category: EconomyBusiness

Markets: United States

Topics: Genetics Corporate restructuring Layoffs Resignations Restructuring IPOs DNA testing Chief executive officer (CEO) Science 23andMe Data breach

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-12 @ 18:14:12 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: fortune.com

Language: English

Article Length: 19 words

Reading Time: 1 minutes read

Sentences: 26 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Fortune

News ID: 23558005

View Article Analysis

About Fortune

Main Topics: EconomyBusiness

Official Website: fortune.com

Update Frequency: 33 posts per day

Year Established: 1929

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #95

Publisher Details

Frequently Asked Questions